Clinical trials · Tucson, AZ
Metabolic Dysfunction-Associated Steatotic Liver Disease clinical trials in Tucson
We’re tracking 6 recruiting metabolic dysfunction-associated steatotic liver disease studies with a site in or near Tucson — including Phase 1/Phase 2, Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Tucson
- NCT06836609RecruitingPhase 1/Phase 2
Study of a new drug for fatty liver disease (MASLD/MASH)
This study tests a new drug called ALN-CIDEB for people with fatty liver disease (MASLD or MASH). The goal is to see if it can reduce liver fat and improve liver health. You may qualify if you have a higher BMI and evidence of liver fat on imaging tests.
Tucson, ArizonaAges 18–65 - NCT06986447Enrolling by invitation
Non-invasive tests for serious liver disease
This study is testing whether advanced imaging and other non-invasive methods can properly identify people with significant liver scarring due to metabolic liver disease or alcohol-related liver disease. It may help find better ways to track liver health without repeated needle biopsies.
Tucson, ArizonaAges 18–80 - NCT07288138RecruitingPhase 2
Study of a New Drug for MASH (Fatty Liver Disease)
This study is testing a new drug that targets thyroid hormone receptors in the liver, alone or combined with another drug, to reduce inflammation and scarring in people with MASH (a type of fatty liver disease). If you have MASH with moderate liver scarring and are otherwise healthy, this trial may help find a new treatment option.
Tucson, ArizonaAges 18–75 - NCT07165028RecruitingPhase 3
Study of new drugs for fatty liver with scarring
This trial tests new medicines for adults with fatty liver disease (MASLD) that has already caused some liver scarring. It aims to see if these drugs can help prevent the liver disease from getting worse.
Tucson, ArizonaAges 18 years+ - NCT06318169RecruitingPhase 3
Testing pegozafermin for MASH and liver fibrosis
This trial tests an experimental drug called pegozafermin to see if it can help people with MASH (a fatty liver disease) and liver scarring (fibrosis). It's for people who have moderate-to-advanced scarring but not cirrhosis, and who have not had other serious liver conditions or poorly controlled diabetes.
Tucson, ArizonaAges 18–80 - NCT07298213Recruiting
Corazones Unidos Study for liver health
This study looks at whether having a family member or close friend join you can help improve liver health in Mexican-origin adults with fatty liver disease. You and your support person will participate together.
Tucson, ArizonaAges 18 years+
Hear when a new Metabolic Dysfunction-Associated Steatotic Liver Disease trial opens near Tucson, AZ
We’ll email you when one opens near Tucson, AZ — at most once a week, no account needed, unsubscribe anytime.
Metabolic Dysfunction-Associated Steatotic Liver Disease trials in other cities
Where these studies are running near Tucson
Institutions with a site for the recruiting metabolic dysfunction-associated steatotic liver disease studies listed above.
- Arizona Liver Health · 3 studies
- Adobe Clinical Research · 2 studies
- Del Sol Research Management
- Tucson Clinical Trial Sites (Unidentified)
- UA Collaboratory for Metabolic Disease Prevention & Treatment
What taking part in a metabolic dysfunction-associated steatotic liver disease study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting metabolic dysfunction-associated steatotic liver disease studies in Arizona.
Common questions
- Are there metabolic dysfunction-associated steatotic liver disease clinical trials near Tucson?
- Yes. We're currently tracking 6 recruiting metabolic dysfunction-associated steatotic liver disease studies with a site near Tucson, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a metabolic dysfunction-associated steatotic liver disease study near Tucson?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Tucson to take part?
- Not necessarily. These studies have a site near Tucson, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a metabolic dysfunction-associated steatotic liver disease trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New metabolic dysfunction-associated steatotic liver disease studies open near Tucson regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.